Regenerative Medicine Market in the US 2016-2020

Category : Pharmaceuticals  | Published Date : Dec-2015 | Pages : 77
 Market outlook of the regenerative medicine market in the US

Regenerative medicine deals with the process of using therapeutically-induced or laboratory grown human tissue to treat diseased or injured human cells, tissues, or organs. It is an emerging field of treatment that helps in producing new cells to substitute malfunctioning or injured cells as a vehicle to treat disease and injury. The regenerative medicine market can be characterized into three major modalities, namely tissue engineering, biomaterials/biomolecules, and stem cell therapy.

Technavio market research analysts expect the regenerative medicine market in the US to grow at a fast pace, posting a remarkable CAGR of more than 33% during the forecast period because of the growing demand for tissue-engineered and stem cell products for the treatment of various diseases. The potential of these medicines in regenerating diseased organs is one of the major factors that drives the market in the US. The stem cells application and advancements in nanotechnology will further drive the progress in this market.

Segmentation by product and analysis of - cell therapy and scaffold

Cell therapy helps in treating the diseases or to improving the functioning of the existing cells, by administrating of cells into the body. This therapy addresses medical conditions related to the bone, cartilage, heart, skin, digestive system, reproductive system, eye, blood, spine, brain, and the nervous system. In 2015, cell therapy segment accounted for approximately 80% of the market share.

The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -

Cell therapy
Segmentation by application and analysis of - dermatology, musculoskeletal, ocular, and cardiovascular

The year 2015 saw the precedence of the dermatology segment, accounting for a market share of more than 51%. Dermatology includes the treatment of burns and chronic wounds that requires a quick response, and skin grafting is essential in many cases. Factors such as the increase in obesity and diabetes, growing elderly population, and an increase in life expectancy are some of the causes contributing to the growth of the dermatology market.

The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -

Competitive landscape and key vendors - AkzoNobel, Jotun, PPG

Regenerative medicine market in the US is highly competitive and fragmented because of the presence of several established vendors and this competitive environment is expected to intensify with advances in R&D and technological innovations. International players are likely to acquire regional or local players to enhance their products and expand their market share during the forecast period.

The top vendors in the market are -

Other prominent vendors include  Aastrom Biosciences, Acologix, AlloCure, Allosource, Alphatec Spine, Altrika, Amorcyte, Argos Therapeutics, Athersys, Avita Medical, Axogen, Bacterin International, Baxter, Bellicum Pharmaceuticals, BioCardia, BioLife Solutions, BioRestorative Therapies, BioTissue Technologies, Bluebird Bio, BrainStorm Cell Therapeutics, Calimmune, Capricor, Celyad (Cardio3 BioSciences), Cell Medica, Cesca, CryoLife, Cynata Therapeutics, Cytori, Cytori Therapeutics, Dendreon, DiscGenics, Fate Therapeutics, Fibrocell, Fibrocell Science, Forticell Bioscience, Fortress Biotech, Gamida Cell, Geron, Harvard Apparatus Regenerative Technology, Healthpoint, Histogen, Histogenics, Humacyte, Immunocellular Therapeutics P, Integra Life Sciences, Intercytex, InVivo Therapeutics, iSTO Technologies, Juventas Therapeutics, Kensey Nash, Kiadis Pharma, Kinetic Concept, Living Cell Technologies, MaxCyte, Medtronics, Mesoblast, MiMedix Group, Nanofiber Solutions CTO, Nanotope, Neuralstem, Newlink Genetics, Northwest Biotherapeutics, NovaRx, Ocata Therapeutics, Opexa , Therapeutics, Organovo Holdings, Orteq, Orthofix, Osiris Therapeutics, Osteotech, Pfizer, Pluristem Therapeutics, Prima BioMed, Q Therapeutics, RhinoCyte, RTI Surgical, SanBio, Sangamo, Shire Regenerative Medicine, StemCells, Stratatech, TEI Biosciences, Tengion, Thermo Fischer Scientific, TiGenix, Tissue Genesis, TissueGene, VentriNova, Vericel, ViaCyte, Vistagen, and Zimmer.

Key questions answered in the report include

What will the market size and the growth rate be in 2020?
	What are the key factors driving the regenerative medicine market in the US?
	What are the key market trends impacting the growth of the regenerative medicine market in the US?
	What are the challenges to market growth?
	Who are the key vendors in the regenerative medicine market in the US?
	What are the market opportunities and threats faced by the vendors in the regenerative medicine market in the US?
	What are the key outcomes of the five forces analysis of the regenerative medicine market in the US?
Technavio also offers customization on reports based on specific client requirement.

Related reports

Global Stem Cell Banking Market 2015-2019
	Global Human Insulin Market 2015-2019
	Global Cell Counting Market 2015-2019
	Global Tissue Diagnostics Market 2014-2018
	Global Orthopedic Soft Tissue Repair Devices Market 2014-2018
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
Market overview
Top vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Gene therapy: An emerging field in regenerative medicine
PART 06: Pipeline portfolio
PART 07: Regulatory scenario
FDA process
PART 08: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 09: Market segmentation by product
Cell therapy
Cell therapy market in US
Scaffold market in US
PART 10: Market segmentation by application
PART 11: Market drivers
Rise in prevalence of chronic diseases
Technological innovations
Increase in investment for research and development activities
PART 12: Impact of drivers
PART 13: Market challenges
Stringent regulatory approval process
Ethical challenges
Lack of clinical data
PART 14: Impact of drivers and challenges
PART 15: Market trends
Increase in pipeline products
Strategic alliances
Potential of regenerative medicine toward decreasing healthcare costs
PART 16: Vendor landscape
Competitive scenario
Key news
Mergers and acquisitions
Key vendor analysis 2015
Other prominent vendors
PART 17: Key vendor analysis
PART 18: Appendix
List of abbreviations
PART 19: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Number of ongoing clinical trials
Exhibit 03: Gene therapy pipeline products based on indication
Exhibit 04: Gene therapy research by sponsorship
Exhibit 05: Some of the pipeline products of gene therapy
Exhibit 06: Pipeline products of regenerative medicine for cardiovascular diseases
Exhibit 07: Pipeline products of regenerative medicine for central nervous system diseases
Exhibit 08: Pipeline products of regenerative medicine for spine and orthopedics diseases
Exhibit 09: Pipeline products of regenerative medicine for diabetes and autoimmune diseases
Exhibit 10: Overview of number of companies and products of regenerative medicine
Exhibit 11: Financial performance of regenerative medicine 2013 and 2014
Exhibit 12: Marketed products of different therapy areas in 2014
Exhibit 13: Regenerative medicine stakeholders
Exhibit 14: Guidelines to be followed prior to the initiation of clinical studies for regenerative products
Exhibit 15: Regenerative medicine market in US 2015-2020 ($ millions)
Exhibit 16: Five forces analysis
Exhibit 17: Cell therapy procedure
Exhibit 18: Cell therapy market in US 2015-2020 ($ millions)
Exhibit 19: Scaffold market in US 2015-2020 ($ millions)
Exhibit 20: Segmentation of regenerative medicine market in US 2015-2020 ($ millions)
Exhibit 21: Segmentation of regenerative medicine market in US 2015-2020
Exhibit 22: Segmentation of regenerative medicine by application 2015
Exhibit 23: Revenues funded by federal agencies for regenerative medicine research
Exhibit 24: Impact of drivers
Exhibit 25: Impact of drivers and challenges
Exhibit 26: Some of the mid- and late-stage pipeline products for regenerative medicine
Exhibit 27: Mesoblast: Key takeaways
Exhibit 28: Reprocell: Key takeaways
Exhibit 29: Acelity: Key takeaways
Exhibit 30: Organogenesis: Key takeaways
Exhibit 31: Stryker: Key takeaways
Exhibit 32: Acelity: Business segmentation by revenue 2014
Exhibit 33: Acelity: Business segmentation by revenue 2013 and 2014
Exhibit 34: Acelity: Geographical segmentation by revenue 2014
Exhibit 35: Mesoblast: Product pipeline
Exhibit 36: Organogenesis: Product offerings
Exhibit 37: Reprocell: Product categories
Exhibit 38: Stryker: Business/product segmentation by revenue 2014
Exhibit 39: Stryker: Business segmentation by revenue 2013 and 2014 ($ millions)
Publisher Name : Technavio


Please Select Format
Single User: US $ 2500
Five User: US $ 3000
Site User: US $ 4000
Global User: US $ 10000

Contact us
Call us +1-971-202-1575
--- or ---
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.